A special communication from JAMA Psychiatry
With the added physical and mental health, social, and economic burdens imposed by the pandemic, many populations worldwide may experience increased suicide risk. However, increases in suicide rates are not a foregone conclusion even with the negative effects of the pandemic.
COVID-19 presents a new and urgent opportunity to focus political will, federal investments, and global community on the vital imperative of suicide prevention. Suicide prevention in the COVID-19 era requires addressing not only pandemic-specific suicide risk factors, but also pre-pandemic risk factors. This Special Communication provides prioritized, evidence-based strategies for clinicians and health care delivery systems, along with national and local policy and educational initiatives tailored to the COVID-19 environment. If implemented to scale, these interventions could significantly mitigate the pandemic’s negative effects on suicide risk.
Provisional data for 2020 show that
despite the increase in some risk factors associated with suicidal behavior during 2020, the number of suicides in the United States appeared to decline in 2020 by 3% compared with 2019.